Univest
Univest
  • Markets

Abbott India Share Price Target 2026: Stock Analysis, Share Price Today, Bull Case and Bear Case After Q1 FY27

  • May 13, 2026
  • Posted by: Ankit Jaiswal
  • Category: News
No Comments
Abbott India Share Price Target 2026: Stock Analysis, Share Price Today, Bull Case and Bear Case After Q1 FY27

Abbott India Rs 26,840 (1 Oct 2026). 52-week range Rs 25,135 to Rs 30,655. Q1 FY27 profit Rs 429 cr, up 17%. P/E 35.3x.

Quick Answer

The Abbott India share price target for 2026 is Rs 29,700 to Rs 32,400 in the Univest base case, with a bull case of Rs 36,100 to Rs 38,000 and a bear case of Rs 23,800 to Rs 25,500, against a last close of Rs 26,840.00. Abbott India reported Q1 FY27 profit up 17 percent to Rs 429 crore on revenue growth of only 4.3 percent, because EBITDA margin widened to 28.81 percent from 25.63 percent. The stock is down about 10 percent in a year, trades at 35.3 times earnings against an industry average near 50 times, and carries almost no debt. No brokerage price target was available on the sources we track as of 5 October 2026, so these ranges are Univest research scenarios based on earnings per share and valuation multiples.

The Abbott India share price target for 2026 is Rs 29,700 to Rs 32,400 in the Univest base case, with the stock at Rs 26,840.00 on 1 October 2026. That is 12.4 percent below its 52-week high of Rs 30,655.00 and 6.8 percent above its 52-week low of Rs 25,135.00, and the stock moved down 10.4 percent over the past year. Abbott India is a pharmaceutical company with a return on equity of 32.5 percent, almost no debt and a dividend yield of 2.44 percent. Revenue grew 4.3 percent in Q1 FY27 while profit grew 17.1 percent.

Three things changed since the last update: Q1 FY27 results were filed on 12 August 2026, Sudarshan Jain took over as Chairman on 13 August, and the stock retested its 52-week low of Rs 25,135 in September. This Abbott India stock analysis covers the Abbott India share price today, the Abbott India share price target for 2026, 2027 and 2030, the Q1 FY27 numbers, catalysts and risks, key price levels and a Abbott India buy or sell view.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • What Is the Abbott India Share Price Target for 2026?
    • Abbott India Share Price Target Scenarios: Bull Case, Base Case and Bear Case
  • Abbott India Company Overview and Share Price Today as of 5 October 2026
  • How Did Abbott India Perform in Q1 FY27?
  • Why Is Abbott India Share Price Down 10 Percent in a Year?
  • Key Catalysts for the Abbott India Share Price Target in 2026
    • 1. Margin Expansion
    • 2. Revenue Growth Pickup
    • 3. Cash-Rich Balance Sheet
    • 4. Valuation Gap to the Sector
  • What Are the Key Risks to the Abbott India Share Price Target?
    • Slow Revenue Growth
    • Premium Book Multiple
    • Price Controls
    • Thin Liquidity
  • Abbott India Stock Analysis: Support and Resistance Levels
  • Abbott India Share Price Target 2026, 2027 and 2030: Short, Medium and Long Term
    • Short-Term Abbott India Share Price Target (3 to 6 Months)
    • 12-Month and 2027 Abbott India Share Price Target
    • Long-Term Abbott India Share Price Target for FY29 to 2030
  • Bull Case and Bear Case for Abbott India Share Price Target
    • Bull Case Rs 36,100 to Rs 38,000
    • Bear Case Rs 23,800 to Rs 25,500
  • Is Abbott India a Good Buy at Rs 26,840? Abbott India Buy or Sell View
  • How to Invest in Abbott India Shares
  • Conclusion
  • FAQs on Abbott India Share Price Target 2026
    • What is the Abbott India share price target for 2026?
    • What is the Abbott India share price target for 2027?
    • Is Abbott India a good buy at Rs 26,840.00?
    • What are the key risks to the Abbott India share price target?
    • What are the key catalysts for the Abbott India share price?
    • Where can I track Abbott India share price today and target updates?
    • What are Abbott India’s 52-week high and low?
    • How to buy Abbott India shares?

What Is the Abbott India Share Price Target for 2026?

The 2026 target for Abbott India shares is Rs 29,700 to Rs 32,400 in the Univest base case, which is +10.7% to +20.7% against the last close. The bull case is Rs 36,100 to Rs 38,000 and the bear case is Rs 23,800 to Rs 25,500. No brokerage price target was available on the sources we track as of 5 October 2026, so every range below is a Univest research scenario. Analyst consensus is used as a cross-check, not as the base.

Abbott India Share Price Target Scenarios: Bull Case, Base Case and Bear Case

Scenario FY28E EPS Target Multiple Price Target (Rs) Move vs Rs 26,840.00
Bull Case Rs 950 38x to 40x 36,100 to 38,000 +34.5% to +41.6%
Base Case Rs 900 33x to 36x 29,700 to 32,400 +10.7% to +20.7%
Bear Case Rs 850 28x to 30x 23,800 to 25,500 -11.3% to -5.0%

FY28 EPS of Rs 900 in the base case is about 18 percent above trailing EPS of Rs 759.85 and about 12 percent above the Q1 FY27 annualised figure of Rs 806. The bull case needs revenue growth to move into double digits while margin holds near 29 percent, and the bear case assumes margin slips back toward 26 percent. The PE multiple used for each case is shown in the table, and the EPS estimate is a Univest assumption, not company guidance. This is what sets the Abbott India share price target range around the current price.

Abbott India Company Overview and Share Price Today as of 5 October 2026

Abbott India share price today is Rs 26,840.00 on the NSE, which is the last close from 1 October because markets were shut on 2 October. The market capitalisation is Rs 57,018 crore, and the stock trades at 35.3 times earnings against an industry average of 50.5 times. The Univest base case Abbott India share price target of Rs 29,700 to Rs 32,400 is +10.7% to +20.7% from here.

Parameter Value Context
NSE Ticker ABBOTINDIA BSE code 500488
Sector Pharmaceuticals Per Univest sector classification
Last Close (NSE) Rs 26,840.00 1 Oct 2026
52-Week High Rs 30,655.00 CMP is 12.4% below
52-Week Low Rs 25,135.00 CMP is 6.8% above
1-Year Return About -10% Weekly close Rs 29,965 on 3 Oct 2025 to Rs 26,840
Market Capitalisation Rs 57,018 crore Mid cap pharma
Trailing P/E About 35.3x Industry P/E about 50.5x
P/B Ratio About 11.94x Book value Rs 2,246.68 per share
EPS (TTM) Rs 759.85 Trailing twelve months
Return on Equity About 32.5% Debt to equity 0.04
Dividend Yield About 2.44% Paid out of surplus cash
12-Month Target (Base Case) Rs 29,700 to Rs 32,400 Univest base case
Bull Case Rs 36,100 to Rs 38,000 +34.5% to +41.6%
Bear Case Rs 23,800 to Rs 25,500 -11.3% to -5.0%

Track live price, fundamentals and results for Abbott India on the Univest Screener.

How Did Abbott India Perform in Q1 FY27?

Abbott India reported Q1 FY27 revenue from operations of Rs 1,813.68 crore, up 4.3 percent, and net profit of Rs 428.52 crore, up 17.1 percent from Rs 365.86 crore. EBITDA rose 17.3 percent to Rs 522.4 crore, and the EBITDA margin widened to 28.81 percent from 25.63 percent. The results were approved on 12 August 2026.

Metric Q1 FY27 Context
Revenue from Operations Rs 1,813.68 crore Up 4.3% year on year
EBITDA Rs 522.4 crore Up 17.3%; margin 28.81% vs 25.63%
Profit Before Tax Rs 572.21 crore Up from Rs 493.13 crore
Net Profit Rs 428.52 crore Up 17.1% from Rs 365.86 crore
EPS (Q1 FY27) Rs 201.66 Against Rs 172.17 a year earlier

Profit growth came from margin, not volume: other income of Rs 75.37 crore also supported pre-tax profit. A sustained 28 to 29 percent margin and revenue growth above 8 percent would justify the base case. The FY27 outlook from management is the main input for these estimates. These numbers sit behind every Abbott India share price target in the scenario table above.

Why Is Abbott India Share Price Down 10 Percent in a Year?

Abbott India shares are down about 10 percent in a year because revenue growth of 4 percent has lagged the premium multiple the stock carried. The stock touched Rs 30,655 in the week of 24 November 2025 and made a 52-week low of Rs 25,135 in the week of 7 September 2026.

The recovery since then is modest: the stock closed at Rs 26,840, about 6.8 percent above the low. A higher margin has lifted profit, but the market wants to see sales growth pick up before paying a higher multiple. The Abbott India share price target scenarios below account for that move.

Key Catalysts for the Abbott India Share Price Target in 2026

4 catalysts matter most for the stock, and sector tailwinds in Pharmaceuticals are part of the case. Together they decide whether the Abbott India share price target in the base case is reached.

1. Margin Expansion

EBITDA margin widened to 28.81 percent in Q1 FY27 from 25.63 percent a year earlier. Holding that level on higher sales would lift EPS above Rs 900. This supports the Abbott India share price target.

2. Revenue Growth Pickup

Revenue grew only 4.3 percent in Q1 FY27. Growth near 8 to 10 percent would move earnings toward the bull case. It is a key input for the Abbott India share price target.

3. Cash-Rich Balance Sheet

Debt to equity is 0.04 and the dividend yield is 2.44 percent. That gives the Abbott India stock target range an income floor. Watch it closely when tracking the Abbott India share price target.

4. Valuation Gap to the Sector

At 35.3 times earnings against an industry average of 50.5 times, Abbott India trades at a discount to its sector. A rise in growth would narrow that gap. It feeds directly into the Abbott India share price target.

What Are the Key Risks to the Abbott India Share Price Target?

The main risks are slow sales growth, a premium book multiple, price controls and thin trading volume. Each can pull the Abbott India share price target lower.

Slow Revenue Growth

Revenue grew 4.3 percent in Q1 FY27 against 17.1 percent profit growth. If margin gains stop, profit growth would fall toward sales growth. It is a downside risk to the Abbott India share price target.

Premium Book Multiple

The stock trades at 11.9 times book value of Rs 2,246.68. A de-rating toward 10 times book would put the price near Rs 22,500. This could pull the Abbott India share price target lower.

Price Controls

Government price controls on essential medicines can cap realisations on part of the portfolio. Any tightening would hit margin. Investors should weigh it against the Abbott India share price target.

Thin Liquidity

A stock priced above Rs 26,000 trades small volumes. Large orders can move the price, so limit orders matter. It is the main swing factor for the bear case of the Abbott India share price target.

Abbott India Stock Analysis: Support and Resistance Levels

Abbott India stock analysis on weekly charts shows a range of Rs 25,135 to Rs 28,940 since September, with the stock holding above its 52-week low.

The first support level is Rs 25,135 to Rs 25,550, the low of the week of 7 September and the April low near Rs 25,150. Below that, Rs 24,500 would be a fresh 52-week low, and a weekly close under Rs 25,135 would weaken the base.

The first resistance level is Rs 27,490 to Rs 27,850, capped by the highs of the weeks of 14 and 28 September. Above that, Rs 28,000 to Rs 28,940 marks the July highs. These levels come from weekly price action, are not trade recommendations, and frame the near-term Abbott India share price target.

Abbott India Share Price Target 2026, 2027 and 2030: Short, Medium and Long Term

Short-Term Abbott India Share Price Target (3 to 6 Months)

In the near term the stock is likely to trade between Rs 25,500 and Rs 28,000, from the September support to the July highs. A close above Rs 27,850 would put Rs 28,940 in play, while a break under Rs 25,135 would invalidate the range. The Q2 FY27 results are the main trigger. This range anchors the near-term Abbott India share price target.

12-Month and 2027 Abbott India Share Price Target

The 12-month target price is Rs 29,700 to Rs 32,400, valued on 33 to 36 times FY28 EPS of Rs 900. The range across scenarios runs from Rs 23,800 in the bear case to Rs 38,000 in the bull case.

Long-Term Abbott India Share Price Target for FY29 to 2030

For FY29 to 2030 the Univest scenario range is Rs 33,600 to Rs 41,300. This assumes EPS of Rs 1,050 in FY29 and Rs 1,180 in FY30 and a multiple of 32 to 35 times. It needs revenue growth to recover and margin to hold near 28 percent. This is the long-term Abbott India share price target in the Univest scenarios.

Bull Case and Bear Case for Abbott India Share Price Target

Bull Case Rs 36,100 to Rs 38,000

The bull case of Rs 36,100 to Rs 38,000 for the Abbott India share price target needs revenue growth in double digits and margin near 29 percent. It is +34.5% to +41.6% from the last close.

Bear Case Rs 23,800 to Rs 25,500

The bear case of Rs 23,800 to Rs 25,500 for the Abbott India share price target equals 28 to 30 times FY28 EPS of Rs 850 and sits near the Rs 25,135 low. It is -11.3% to -5.0% from the last close.

Is Abbott India a Good Buy at Rs 26,840? Abbott India Buy or Sell View

Whether Abbott India is a buy at Rs 26,840.00 depends on horizon and risk appetite. The base case implies about 11 to 21 percent upside, the stock trades at a discount to the sector multiple, and the open question is revenue growth. The Abbott India share price target range is the starting point for that decision.

Long-term holders may focus on 32.5 percent return on equity, zero-debt balance sheet and the 2.44 percent dividend yield, and treat Rs 25,135 as the level to watch. Short-term traders may prefer to wait for a close above Rs 27,850. Check institutional holding in the September quarter filing for signs of accumulation or selling. Consult a SEBI-registered advisor before acting, since this Abbott India buy or sell view is educational.

How to Invest in Abbott India Shares

Step 1: Check the live price, valuation and the latest Abbott India share price target range on the Univest Screener.

Step 2: Open a demat and trading account with a SEBI-registered broker such as Univest before acting on any Abbott India share price target.

Step 3: Search for ABBOTINDIA on the NSE or 500488 on the BSE in your trading app.

Step 4: Place a limit order near your planned entry and size the position so a fall to Rs 23,800 is bearable.

Step 5: Track Q2 FY27 results, revenue growth and margin and set price alerts on the Univest App.

Conclusion

Abbott India closed at Rs 26,840.00 against a Univest base case share price target of Rs 29,700 to Rs 32,400, a bull case of Rs 36,100 to Rs 38,000 and a bear case of Rs 23,800 to Rs 25,500. Q1 FY27 delivered a 17.1 percent profit rise to Rs 428.52 crore on 4.3 percent revenue growth, with EBITDA margin at 28.81 percent. The main risks are slow sales, the premium book multiple and price controls.

The stock is 12.4 percent below its 52-week high, so the base case implies roughly 11 to 21 percent upside. The triggers to watch are the Q2 FY27 results, revenue growth and the Rs 25,135 and Rs 27,850 levels. Re-check the Abbott India share price target after each quarterly result. Investors with a long horizon and tolerance for volatility can track these triggers, while others may prefer to size positions carefully.

Download the Univest iOS App or Univest Android App to track Abbott India live price and get daily stock recommendations.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on Abbott India Share Price Target 2026

What is the Abbott India share price target for 2026?

Ans. The Abbott India share price target for 2026 is Rs 29,700 to Rs 32,400 in the Univest base case, with a bull case of Rs 36,100 to Rs 38,000 and a bear case of Rs 23,800 to Rs 25,500. No brokerage target was available on the sources we track as of 5 October 2026, so these are Univest research scenarios. These are estimates and can change after the Q2 FY27 results.

What is the Abbott India share price target for 2027?

Ans. The Abbott India share price target for 2027 is Rs 29,700 to Rs 32,400 in the base case, valued on 33 to 36 times FY28 EPS of Rs 900. The scenario range runs from Rs 23,800 to Rs 38,000.

Is Abbott India a good buy at Rs 26,840.00?

Ans. Whether Abbott India is a good buy at Rs 26,840.00 depends on your horizon and risk appetite. The stock trades at about 35 times earnings against an industry average near 50 times, with 32.5 percent return on equity and almost no debt, but revenue growth is only 4.3 percent. Consult a SEBI-registered advisor before investing.

What are the key risks to the Abbott India share price target?

Ans. The key risks to the Abbott India share price target are slow revenue growth, premium book multiple, price controls and thin liquidity. Revenue grew 4.3 percent in Q1 FY27 against 17.1 percent profit growth. If margin gains stop, profit growth would fall toward sales growth.

What are the key catalysts for the Abbott India share price?

Ans. The key catalysts for the Abbott India share price target are margin expansion, revenue growth pickup, cash-rich balance sheet and valuation gap to the sector. EBITDA margin widened to 28.81 percent in Q1 FY27 from 25.63 percent a year earlier. Holding that level on higher sales would lift EPS above Rs 900.

Where can I track Abbott India share price today and target updates?

Ans. You can track the live Abbott India share price, results and any change to the Abbott India share price target on the Univest Screener and the Univest App. Download the Univest iOS App or Univest Android App for research from SEBI-registered analysts.

What are Abbott India’s 52-week high and low?

Ans. Abbott India’s 52-week high is Rs 30,655.00 and its 52-week low is Rs 25,135.00, based on weekly NSE data. At Rs 26,840.00 the stock is 12.4 percent below the high and 6.8 percent above the low. Both levels frame the Abbott India share price target.

How to buy Abbott India shares?

Ans. Open a demat account with a SEBI-registered broker such as Univest, search for ABBOTINDIA on the NSE or 500488 on the BSE, and place a limit order near your entry price, using the Abbott India share price target range as a guide. Size the position so a fall to Rs 23,800 is bearable, and check the live price on the Univest Screener first.



Abbott India Q1 FY27 results Abbott India share price target Abbott India share price today Abbott India stock analysis Abbott India target price
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply